Skip to content
Use caution Drug recall · FDA · Published May 31, 2018

Apotex Fluticasone Nasal Spray Recall: Glass Particles Hazard

Apotex recalls Fluticasone propionate nasal spray with glass particles. Stop using if you have the recalled product. Details on affected batches and how to return.

🇺🇸 FDA recall #D-0841-2018DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Dr · North York, Canada
✎ GovInfoNow plain-language explainer

Apotex is recalling Fluticasone propionate nasal spray bottles that may contain glass particles. This could cause injury if the particles enter the nasal passages. Affected products were manufactured in Canada and sold in the U.S. with a specific expiration date. Read more at govinfonow.com/recall/40504-apotex-fluticasone-nasal-spray-recall-glass-particles-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/40504-apotex-fluticasone-nasal-spray-recall-glass-particles-hazard · Updated October 7, 2026 · FDA enforcement record: FDA #D-0841-2018

Cite this page

“Apotex Fluticasone Nasal Spray Recall: Glass Particles Hazard.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40504-apotex-fluticasone-nasal-spray-recall-glass-particles-hazard. Based on FDA recall #D-0841-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0841-2018%22&limit=1).

Apotex Inc. voluntarily recalled Fluticasone propionate Nasal Spray, USP, 50 mcg due to the presence of glass particles, the Food and Drug Administration said on May 31, 2018. The Class II recall affects lots manufactured in Toronto, Ontario, Canada.

How to tell if you have it

  • Brand: Apotex
  • Product: Fluticasone propionate Nasal Spray, USP, 50 mcg
  • Packaging: 50 mcg per spray 120 Metered Sprays bottles, 16 g net fill
  • NDC: 60505-0829-1
  • Lot code: NJ4501
  • Expiration date: 07/2020
  • Distribution: Nationwide

The hazard

The recall addresses the presence of foreign substance, specifically glass particles, in the nasal spray bottles. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Apotex Inc. has 19 other recalls on record since April 30, 2012. Other recent recalls of similar products include Apotex Metformin Tablets Recall (May 27, 2020), Apotex Atorvastatin 40mg Tablets Recall (Oct. 22, 2019), and Apotex Wal-Zan 150mg Tablets Recall (Sept. 24, 2019). Other recent recalls of similar products include Apotex Desmopressin Nasal Spray Recall (April 8, 2026), Imprimis Dexamethasone Moxifloxacin Eye Drops Recall (Dec. 18, 2025), and Sun Pharmaceutical DOXOrubin Liposome Injection Recall (May 12, 2026).

How to tell if you have this one

Check for the product name 'Fluticasone propionate Nasal Spray, USP, 50 mcg' in 120 metered spray bottles. The lot number is NJ4501 and expiration date is July 2020.

  • Brand
    Apotex
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number NJ4501 and expiration date of July 2020 on the bottle.

  2. Stop Using if Recalled

    If you have the recalled product, stop using it immediately to avoid potential injury.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 4.3 years after the firm started it.

1. Firm started the recall: May 31, 201812. FDA classified it Class II: Jun 6, 201823. Published in FDA’s Enforcement Report: Jun 13, 201834. FDA terminated the recall: Sep 28, 2022420182022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0841-2018 (May 31, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0841-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA